The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants

Antivirals are urgently needed to combat the global SARS-CoV-2/COVID-19 pandemic, supplement existing vaccine efforts, and target emerging SARS-CoV-2 variants of concern. Small molecules that interfere with binding of the viral spike receptor binding domain (RBD) to the host angiotensin-converting e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tietjen, Ian, Cassel, Joel, Register, Emery T., Zhou, Xiang Yang, Messick, Troy E., Keeney, Frederick, Lu, Lily D., Beattie, Karren D., Rali, Topul, Tebas, Pablo, Ertl, Hildegund C. J., Salvino, Joseph M., Davis, Rohan A., Montaner, Luis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597786/
https://www.ncbi.nlm.nih.gov/pubmed/34543092
http://dx.doi.org/10.1128/AAC.00772-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597786/
https://www.ncbi.nlm.nih.gov/pubmed/34543092
http://dx.doi.org/10.1128/AAC.00772-21

Ejemplares similares